Obagi-C Rx system C-Therapy Night Skin Lightening with Vitamins C and E
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
62032-105 -
Package NDC
62032-105-36 -
SPL ID
2e9d9417-8b73-4d00-9783-c0d14f1a9cbc -
SPL set ID
81e2e734-01fe-4568-903a-92993bf40887 -
UNII
XV74C1N1AE -
RxCUI
197795
What the source publishes
- Labeler
- Obagi Cosmeceuticals LLC
- Active ingredients
- HYDROQUINONE
- Form
- CREAM
- Routes
- TOPICAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- UNAPPROVED DRUG OTHER
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Obagi-C Rx system C-Therapy Night Skin Lightening with Vitamins C and E",
"splId": "2e9d9417-8b73-4d00-9783-c0d14f1a9cbc",
"labels": [
{
"setId": "81e2e734-01fe-4568-903a-92993bf40887",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=81e2e734-01fe-4568-903a-92993bf40887",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=81e2e734-01fe-4568-903a-92993bf40887"
}
],
"routes": [
"TOPICAL"
],
"labeler": "Obagi Cosmeceuticals LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "57 g in 1 BOTTLE, PLASTIC (62032-105-36)",
"package_ndc": "62032-105-36",
"identifierStatus": "well-formed",
"marketing_start_date": "20100101"
}
],
"productId": "62032-105_2e9d9417-8b73-4d00-9783-c0d14f1a9cbc",
"useDomain": "unknown",
"dosageForm": "CREAM",
"productNdc": "62032-105",
"deaSchedule": null,
"genericName": "HYDROQUINONE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "HYDROQUINONE",
"strength": "40 mg/g"
}
],
"applicationNumber": null,
"marketingCategory": "UNAPPROVED DRUG OTHER",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20100101",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175851",
"N0000175854",
"N0000175850"
],
"unii": [
"XV74C1N1AE"
],
"rxcui": [
"197795"
],
"spl_set_id": [
"81e2e734-01fe-4568-903a-92993bf40887"
],
"pharm_class_pe": [
"Depigmenting Activity [PE]"
],
"pharm_class_epc": [
"Melanin Synthesis Inhibitor [EPC]"
],
"pharm_class_moa": [
"Melanin Synthesis Inhibitors [MoA]"
],
"manufacturer_name": [
"Obagi Cosmeceuticals LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:62032-105_2e9d9417-8b73-4d00-9783-c0d14f1a9cbc"